問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
葉坤輝
下載
2017-03-14 - 2025-05-13
Condition/Disease
Locally Advanced or Metastatic Solid Tumors that Entrectinib Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements
Test Drug
Entrectinib
Participate Sites5Sites
Recruiting3Sites
Terminated2Sites
2020-12-01 - 2023-12-31
Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements
Futibatinib（TAS-120）
Participate Sites6Sites
Recruiting6Sites
2020-06-16 - 2023-12-31
Curative Resection of colorectal cancer
LONSURF
Participate Sites1Sites
Recruiting1Sites
全部
